Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: A population study in the Netherlands

Transfusion

Volumn 48, Issue 5, 2008, Pages 941-952

  Koelewijn, J M ^c   Vrijkotte, T G M ^c   Van Der Schoot, C E ^c   Bonsel, G J ^c   De Haas, M ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIBODY; BLOOD GROUP KELL ANTIBODY; ERYTHROCYTE ANTIBODY; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; COHORT ANALYSIS; EXCHANGE BLOOD TRANSFUSION; FEMALE; FETUS; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; HEMOLYTIC ANEMIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCREENING TEST; VALIDATION PROCESS;

ABRUPTIO PLACENTAE; DUFFY BLOOD-GROUP SYSTEM; ERYTHROBLASTOSIS, FETAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HEPATITIS B E ANTIGENS; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; KIDD BLOOD-GROUP SYSTEM; MASS SCREENING; NATIONAL HEALTH PROGRAMS; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTER, FIRST; RH-HR BLOOD-GROUP SYSTEM; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 42949175546     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01625.x     Document Type: Article

References (32)

1. Bowman JM. RhD hemolytic disease of the newborn. N Engl J Med 1998 339 : 1775 7.
2. Levine P, Burnham L, Katzin EM, Vogel P. The role of iso-immunization in the pathogenesis of erythroblastosis fetalis. JAMA 1941 113 : 126 7.
3. Mollison PL, Engelfriet CP, Contreras M. Haemolytic disease of the fetus and the newborn. In : Mollison PL, Engelfriet CP, Contreras M, editors. Blood transfusion in clinical medicine. 10th ed., Vol. 10. Oxford : Blackwell Science 1997. p. 390 424.
4. Daniels G. Blood group antibodies in haemolytic disease of the fetus and newborn. In : Hadly A, Soothill P, editors. Alloimmune disorders of pregnancy. Vol. 1. Cambridge : Cambridge University Press 2002. p. 2 1 40.
5. Urbaniak SJ, Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000 14 : 44 61.
6. Moise KJ Jr. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000 92 : 75 81.
7. Moise KJ. Red blood cell alloimmunization in pregnancy. Semin Hematol 2005 42 : 169 78.
8. Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986 154 : 85 90.
9. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996 174 : 547 51.
10. Bowell PJ, Brown SE, Dike AE, Inskip MJ. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol 1986 93 : 1044 8.
11. Council of Health Insurances. Blood testing in pregnancy. Pregnancy immunization, hepatitis B and lues [booklet in Dutch]. Inspection Public Health. The Hague : Council of Health Insurances 1998.
12. Wilson JM, Jüngner G. Principles and practice of screening for disease. Public Health Papers, Vol. 34. Geneva : World Health Organization 1968.
13. Stichting Perinatale Registratie Nederland. Perinatal care in the Netherlands 2003 [in Dutch]. Vol. 116. Bilthoven : SPRN 2006.
14. van der Ploeg CP, Anthony S, Rijpsta A, Verkerk PH. Process monitoring pre- and postnatal screenings 2003 [report in Dutch]. Leiden : TNO Quality of Life 2006.
15. Quality Institute of Healthcare and evidence-based guideline development (CBO). Guide line blood transfusion. Alphen aan den Rijn : Van Zuiden 2004. [Dutch guideline].
16. Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, Kanhai HH, Ohlsson A, Ryan G DIAMOND Study Group. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006 355 : 156 64.
17. Vandenbussche FP, Klumper FJ. Red cell immunization and pregnancy. Leiden : Dutch Society of Obstetrics and Gynaecology 2002. [Dutch guideline].
18. Reid M, Lomas-Francis C. The blood group antigen facts book. San Diego : Academic Press 2004 J, Napier JA. Red cell antibodies detected in antenatal tests on rhesus positive women in South and Mid Wales, 1948-1978. Br J Obstet Gynaecol 1981 88 : 91 100.
19. Jovanovic-Srzentic S, Djokic M, Tijanic N, Djordjevic R, Rizvan N, Plecas D, Filimonovic D. Antibodies detected in samples from 21,730 pregnant women. Immunohematol 2003 19 : 89 92.
20. de Vrijer B, Harthoorn-Lasthuizen EJ, Oosterbaan HP. [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the s-Hertogenbosch]. Ned Tijdschr Geneeskd 1999 143 : 2523 7.
21. Hackney DN, Knudtson EJ, Rossi KQ, Krugh D, O'Shaughnessy W. Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 2004 103 : 24 30.
22. Joy SD, Rossi KQ, Krugh D, O'Shaughnessy RW. Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol 2005 105 : 24 8.
23. Bowell PJ, Allen DL, Entwistle CC. Blood group antibody screening tests during pregnancy. Br J Obstet Gynaecol 1986 93 : 1038 43.
24. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995 74 : 687 92.
25. Gottvall T, Selbing A, Hilden JO. Evaluation of a new Swedish protocol for alloimmunization screening during pregnancy. Acta Obstet Gynecol Scand 1993 72 : 434 8.
26. Andersen AS, Praetorius L, Jorgensen HL, Lylloff K, Larsen KT. Prognostic value of screening for irregular antibodies late in pregnancy in rhesus positive women. Acta Obstet Gynecol Scand 2002 81 : 407 11.
27. Rothenberg JM, Weirermiller B, Dirig K, Hurd WW, Schilder J, Golichowski A. Is a third-trimester antibody screen in Rh+ women necessary? Am J Manag Care 1999 5 : 1145 50.
28. Heddle NM, Klama L, Frassetto R, O'Hoski P, Leaman B. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993 33 : 217 20.
29. Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006 46 : 630 5.
30. Schonewille H, Klumper FJ, van de Watering LM, Kanhai H, Brand A. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 2007 196 : 143 6.
31. Van Kamp IL, Klumper FJ, Oepkes D, Meerman R, Scherjon S, Vandenbussche F, Kanhai H. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005 192 : 171 7.
32. Reid M, Lomas-Francis C. The blood group antigen facts book. San Diego : Academic Press 2004. 2. p. 135.